Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02290873 · ClinicalTrials.gov registry record · Phase 3
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
A Phase 3 study of Colonoscopy, sponsored by Paion UK.
- Completed
- Registry status
- Phase 3
- Development phase
- 461
- Enrollment target
- 13
- Study locations
NCT02290873 is a Phase 3 study of Colonoscopy that has completed, run by Paion UK. The registered enrollment target is 461 participants, roughly in line with the 479-participant average among 20 other Colonoscopy trials with a reported enrollment target. The trial reports 13 study locations across 11 states.
The verdict
NCT02290873, a Phase 3 study of Colonoscopy, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 461 participants
- Enrollment target
- 13
- Study locations
Study Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for midazolam, in patients undergoing a colonoscopy for diagnostic or therapeutic reasons.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Midazolam
- DRUG Remimazolam
Study Locations (13)
California
- Advanced Clinical Research Institute - Anaheim
- Precision Research Institute - Chula Vista
- Precision Research Institute - San Diego
Alabama
- University of South Alabama - Mobile
Florida
- Borland-Grover Clinic, P.A - Jacksonville
Indiana
- Indiana University Health - Indianapolis
Louisiana
- Delta Research Partners Inc - Monroe
Missouri
- Washington University School of Medicine - St Louis
North Carolina
- Wake Research Associates - Raleigh
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 461 participants |
| Start Date | 2015-03-30 |
| Est. Completion | 2016-04-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02290873
The ClinicalTrials.gov registry entry for NCT02290873 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 461 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 479-participant average among 20 other Colonoscopy trials with a reported enrollment target. The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02290873 reports 13 study locations spanning 11 distinct geographic areas - top geographies include California, Alabama, Florida.
Frequently Asked Questions
What is clinical trial NCT02290873 about?
NCT02290873 is a clinical study titled "A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients". A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for midazolam, in patients undergoing a colonoscopy for diagnostic or therapeutic reasons.
What is the current status of trial NCT02290873?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 461 participants. The study started on 2015-03-30. Estimated completion is 2016-04-19.
What conditions does trial NCT02290873 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT02290873?
The interventions under investigation include: Placebo (DRUG), Midazolam (DRUG), Remimazolam (DRUG).
Who is sponsoring clinical trial NCT02290873?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02290873 being conducted?
This trial has 13 study locations across Alabama, California, Florida, Indiana, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HalfLytely Bowel Prep System for Colonoscopy
COMPLETED · Phase 3
-
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
COMPLETED · Phase 3
-
BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
COMPLETED · Phase 3
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.